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The Journal of Immunology
PE_PGRS Antigens of Mycobacterium tuberculosis Induce
Maturation and Activation of Human Dendritic Cells
Kushagra Bansal,* Sri Ramulu Elluru,†,‡,x Yeddula Narayana,* Rashmi Chaturvedi,*
Shripad A. Patil,{ Srini V. Kaveri,†,‡,x Jagadeesh Bayry,†,‡,x,1 and Kithiganahalli N. Balaji*,1
Mycobacterium tuberculosis, the causative agent of pulmonary tuberculosis, infects one-third of the world’s population. Activation
of host immune responses for containment of mycobacterial infections involves participation of innate immune cells, such as
dendritic cells (DCs). DCs are sentinels of the immune system and are important for eliciting both primary and secondary immune
responses to pathogens. In this context, to understand the molecular pathogenesis of tuberculosis and host response to mycobac-
teria and to conceive prospective vaccine candidates, it is important to understand how cell wall Ags of M. tuberculosis and, in
particular, the proline-glutamic acid_polymorphic guanine-cytosine–rich sequence (PE_PGRS) family of proteins modulate DC
maturation and function. In this study, we demonstrate that two cell wall-associated/secretory PE_PGRS proteins, PE_PGRS 17
(Rv0978c) and PE_PGRS 11 (Rv0754), recognize TLR2, induce maturation and activation of human DCs, and enhance the ability
of DCs to stimulate CD4+ T cells. We further found that PE_PGRS protein-mediated activation of DCs involves participation of
ERK1/2, p38 MAPK, and NF-kB signaling pathways. Priming of human DCs with IFN-g further augmented PE_PGRS 17 or
PE_PGRS 11 Ag-induced DC maturation and secretion of key proinflammatory cytokines. Our results suggest that by activating
DCs, PE_PGRS proteins, important mycobacterial cell wall Ags, could potentially contribute in the initiation of innate immune
responses during tuberculosis infection and hence regulate the clinical course of tuberculosis. The Journal of Immunology, 2010,
184: 3495–3504.
M
ycobacterium tuberculosis, the causative agent of pul-
monary tuberculosis, infects one-third of the world’s
population (1). The emergence of multidrug-resistant
and extensively drug-resistant strains, alarmingly raising numbers
of patients with coinfection of HIV and tuberculosis and variable
efficacy of immunization with Mycobacterium bovis bacillus
Calmette-Gue´rin, have stressed the urgency of developing novel
therapeutic intervention strategies for tuberculosis (2, 3). There-
fore, identification and characterization of immunodominant my-
cobacterial Ags that are critical in eliciting protective immune
responses is essential to understand host-pathogen interaction and
to develop therapeutic strategies to combat tuberculosis.
Activation of inflammatory responses for containment of myco-
bacterial infections involvesparticipationof innate aswell as adaptive
immunity (4–9). Despite robust host immune responses, M. tuber-
culosis exhibits remarkable ability to survive by interfering with
functions of APCs, the cells critical for eliciting immune responses to
pathogens (10–13).Althoughmycobacteria are suggested topersist in
granulomas of infected hosts, many antigenic proteins are known to
be secreted from the infected macrophages (14–17) that eventually
act as key targets for APCs, such as dendritic cells (DCs), recruited to
the focus of the infection.DCs are sentinels of the immune systemand
are important for eliciting both primary and secondary immune re-
sponses to pathogens (18–23). DCs express diverse cell surface
markers, and phenotypic analysis broadly classifies the DCs into
immature and mature stages. Immature DCs have the ability to cap-
ture and internalizeAgs that involve surface expressed receptors, such
as TLRs, lectin receptors, FcR, and complement receptors. Addi-
tionally, DCs express a number of cytokine receptors, an important
feature in their ability to respond to inflammatory stimuli. In this
perspective, immature DCs operate as immunological sensors to
alert the immune system (19, 21). However, immature DCs are poor
stimulators of diverse types of T cells, and it is necessary for them to
undergomaturation andactivation steps in order initiate robust innate
immunity. In this context, the maturation process is defined by the
series of phenotypic changes that enable DCs to initiate immunity as
professional APCs. This complex process relies on several con-
comitant processes, including loss of endocytic/phagocytic recep-
tors; upregulation of costimulatory and adhesion molecules, such as
CD80, CD86, CD40, CD54, and CD58, the molecules involved in
mediating clustering with and activation of T cells; and secretion of
immunoregulatory cytokines and chemokines, such as IL-1b, IL-6,
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IL-10, IL-12, IL-23, TNF, CCL17, CCL19, and CCL22. Further,
maturation process involves translocation of MHC class I/II com-
partments to the cell surface and eventual migration of mature DCs
into regional/draining lymphoid tissue. This maturation and activa-
tion process renders DCs a high capability to activate Ag-specific
T cells (22, 23).
Studies have suggested that infection of human DCs with M.
tuberculosis results in their maturation reflected by increased
surface expression of maturation markers as well as secretion of
elevated levels of inflammatory cytokines (24–26). Further, in-
fected DCs were shown to restrict the intracellular growth of M.
tuberculosis (27). In this context, it is vital to understand molec-
ular details on how cell wall Ags of M. tuberculosis, and in par-
ticular proline-glutamic acid (PE) and proline-proline-glutamic
acid (PPE) gene family members of M. tuberculosis, modulate DC
maturation and their function.
Ten percent of the coding capacity of M. tuberculosis genome is
devoted to the PE and PPE gene family members, exemplified by the
presence of PE and PPE motifs near the N-terminus of their gene
products (28). Many members of the PE family exhibit multiple
copies of polymorphic guanine-cytosine–rich sequences (PGRSs) at
the C-terminal end, which are designated as the PE_PGRS family of
proteins (29). The uniqueness of the PE genes is further illustrated by
the fact that these genes are restricted to mycobacteria (28, 29).
Several PE genes are reported to be expressed upon infection of
macrophages, and polymorphisms in PGRS region are suggested to
play a critical role in antigenic diversity and to evade host immune
recognition (30, 31).ManyPE/PPEproteins are also known to induce
a strong B cell response in humans (32–35). A number of PE_PGRS
proteins associatewith the cell wall, and following surface exposure,
these proteins traffic out of the mycobacterial phagosome into en-
docytic compartments. In addition, thesePE_PGRSproteins can gain
access to the extracellular environment in the form of exocytosed
vesicles (14, 30, 36, 37). However, little is known about the effect of
PE_PGRS proteins on the maturation and functions of human DCs
and underlying signaling events.
In this study, we demonstrate that two cell wall-associated/se-
cretory PE_PGRSproteins, PE_PGRS 17 (Rv0978c) and PE_PGRS
11 (Rv0754), recognize TLR2 and inducematuration and activation
of human DCs. We further found that PE_PGRS protein-mediated
activation of DCs involves activation of ERK1/2, p38 MAPK, and
NF-kB pathways. Our results suggest that by acting on APCs, such
as DCs, PE_PGRS 17 and PE_PGRS 11 proteins could potentially
regulate immune responses to M. tuberculosis and the clinical
course of tuberculosis.
Materials and Methods
Abs and reagents
Recombinant human IL-4, GM-CSF, and IFN-g were obtained from Im-
munoTools (Friesoythe, Germany). FITC-conjugated mAbs to HLA-DR,
CD80, and CD1a and PE-conjugated mAbs to CD86 and CD83 were from
BD Biosciences (Le Pont-De-Claix Cedex, France), and PE-conjugated
mAb to CD40 was from BD Biosciences. Anti-Thr202/Tyr204 phospho-
ERK1/2, anti-ERK1/2, anti-Thr180/Tyr182 phospho-p38 MAPK, p38
MAPK, and anti–NF-kB p65 Abs were purchased from Cell Signaling
Technology (Beverly, MA). Anti-TLR1, anti-TLR2, anti-TLR4, and anti-
TLR6were procured from Imgenex (SanDiego, CA). Anti–b-actin Ab (AC-
15) was from Sigma-Aldrich (St. Louis, MO).
Expression and purification of PE_PGRS 17 and PE_PGRS 11
The selected PE_PGRS genes were PCR amplified from genomic DNA
using gene-specific primers: 59-GCGGATCCATGTCGTTTGTCAACGT-
GGC-39 (forward) and 59-CGCTCGAGAGCTGATTACCGACACCGTGT-
39 (reverse) for PE_PGRS 17; 59-CGGGATCCATGTCATTTGTGATC-
GTGGCG-39 (forward) and 59-CCCAAGCTTTCATGGGATCAGGCTG-
GGCAG-39 (reverse) for PE_PGRS 11. The amplified PCR product was li-
gated into the pGEMT-Easy vector (Promega, Madison, WI), and the re-
combinant clones carrying the appropriate gene insert were confirmed
by DNA sequencing. The gene inserts were subcloned into pRSET series
vectors for protein expression and purification. Escherichia coli BL21
cells carrying recombinant plasmids were induced with isopropyl-b-D-thi-
ogalactopyranoside, and His-tagged recombinant proteins were purified
with Ni-nitrilotriacetic acid (Ni-NTA) columns (Qiagen, Valencia, CA).
Generation of polyclonal Abs to PE_PGRS 17 and PE_PGRS 11
The polyclonal Abs against PE_PGRS 17 and PE_PGRS 11 were generated
in rabbits by s.c. injection of 1 mg purified proteins emulsified with equal
volume of Freund’s adjuvant (Sigma-Aldrich). The experiments were ap-
proved by the Institutional Ethics Committee for Animal Experimentation
and Institutional Biosafety Committee, Indian Institute of Science, Ban-
galore. The first immunization was carried out with Freund’s complete
adjuvant followed by two booster immunizations with Freund’s incomplete
adjuvant at 21-d intervals. The Ab titers in the serum were determined by
ELISA 2 wk postfinal immunization.
Generation and culture of human DCs
PBMCs were isolated from buffy coats of healthy donors purchased from
Hoˆpital Hoˆtel Dieu, Etablissement Franc¸ais du Sang, Paris, France, upon
ethical approval for the use of such materials. Monocytes from PBMCs
were positively isolated using CD14 magnetic beads (Miltenyi Biotec,
Paris, France). The purity of the monocytes was .98%. Monocytes were
differentiated into immature DCs by culturing them for 7 d in RPMI 1640
containing 10% FCS, 50 U/ml penicillin, 50 mg/ml streptomycin, IL-4
(500 IU/106 cells), and GM-CSF (1000 IU/106 cells). Immature 7-d-old
DCs (0.5 3 106 /ml) were cultured with cytokines alone or cytokines and
individual PE_PGRS protein for 48 h.
Patients with tuberculosis and healthy subjects
The study population was comprised of tuberculosis bacilli-infected
patients (n = 9) or healthy controls (n = 4) reporting to the National In-
stitute of Mental Health and Neurosciences, Bangalore, India. The di-
agnosis of tuberculosis was established based on clinical and radiological
data together with the identification of acid-fast bacilli in sputum. The
healthy donors were negative for active tuberculosis disease. The samples
from HIV-positive subjects were excluded from the study. The study
subjects had given written consent, and the study was approved by the
Institutional Bioethics Committee.
Analysis of the expression of surface molecules by flow
cytometry
Cell surface staining was performed with specifically labeled mAbs, and
samples were proceeded for flow cytometry (LSR II, BD Biosciences). For
each sample, 5000 events were recorded. Data were analyzed using BD
FACSDiva software (BD Biosciences).
MLR
CD4+ T cells used in allogenic MLR were isolated from PBMCs of healthy
donors using CD4 magnetic beads (Miltenyi Biotec). After 48 h of treat-
ment with individual proteins, DCs were washed extensively and cocul-
tured with 1 3 105 responder allogeneic CD4+ T cells at DC:T cell ratios
of 1:10, 1:20, and 1:40. After 4 d, the cells were pulsed for 16–18 h with
0.5 mCi of [3H]thymidine. Radioactive incorporation was measured by
standard liquid scintillation counting. The proliferation of cells was mea-
sured as cpm (mean 6 SEM of quadruplicate values) after subtracting
values of responder T cell cultures alone.
Analysis of cytokines
Cytokines were quantified in cell-free culture supernatants using BD CBA
Human Inflammation kit and Human Th1/Th2 kits (BD Biosciences).
Treatment of DCs with pharmacological inhibitors of signaling
pathways
All the pharmacological inhibitors were obtained from Calbiochem (San
Diego, CA). They were reconstituted in sterile, cell-culture grade DMSO
(Sigma-Aldrich) and used at following concentrations after determining
the viability of DCs in titration experiments using MTT assay: U0126
(10 mM), SB203580 (1 mM), SP600125 (10 mM), Bay 11-0782 (20 mM),
and TPCK (20 mM). DMSO at 0.1% concentration was used as the vehicle
control. In experiments with inhibitors, the cells were treated with a given
inhibitor for 60 min before treatment with individual proteins. Addition-
ally, when a given inhibitor was tested, its efficacy in terms of inhibition of
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phosphorylation of intended signaling molecule as well as a nonintended
signaling molecule was also tested (for example, SB203580 inhibits TNF-
a–triggered p38, but not ERK1/2 phosphorylation).
Immunoblotting analysis
Total cell lysates were prepared after washing the cells briefly with ice-cold
PBS in 13 radio immunoprecipitation assay lysis buffer (50 mM Tris-HCl
[pH7.4], 1%Nonidet P-40 [NP-40], 0.25%Na-deoxycholate, 150mMNaCl,
1 mMEDTA, 1mMPMSF, 1mg/ml each aprotinin, leupeptin, and pepstatin,
1 mM Na3VO4, 1 mM NaF). Equal amounts of proteins from each sample
were subjected to SDS-PAGE followed by transfer of proteins to poly-
vinylidene difluoride membranes (Millipore, Bedford, MA). Membranes
were blocked in TBST buffer (0.02 M Tris-HCl [pH 7.5], 0.15 M NaCl and
0.1% Tween 20) containing 5% nonfat dried milk and probed with a primary
Ab overnight at 4˚C. After washing with TBST, membranes were incubated
with secondary Ab linked to HRP (Jackson ImmunoResearch Laboratories,
West Grove, PA). The blots were then developed with an ECL detection
system (PerkinElmer,Wellesley,MA) as per themanufacturer’s instructions.
Nuclear and cytosolic subcellular fractionation
DCs were washed with ice-cold PBS and gently resuspended in ice-cold
Buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM
EGTA, 1 mM DTT, and 0.5 mM PMSF). Postincubation on ice for 15 min,
cell membranes were disrupted with 10% NP-40, and the nuclear pellets
were recovered by centrifugation at 13,000 3 g for 15 min at 4˚C. The
supernatants from this step were used as cytosolic extracts. Nuclear pellets
were lysed with ice-cold Buffer C (20 mM HEPES [pH 7.9], 0.4 M NaCl, 1
mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM PMSF), and nuclear
extracts were collected postcentrifugation at 13,000 3 g for 20 min at 4˚C.
Transient transfections and immunoflourescence
HEK-293 cells were transiently transfected with TLR2 or TLR2 dominant-
negative constructs using ESCORT III (Sigma-Aldrich). For immuno-
flourescence studies, vector or TLR2 cDNA construct-transfected HEK-293
cells and DCs were seeded in a 35-mm dish on cover slips. On the day of
experiment, HEK-293 cells were washed and treated with 2 mg/ml purified
PE_PGRS 17 or PE_PGRS 11 proteins for 1 h, whereas DCs were pretreated
with either anti-TLR1, -TLR2, -TLR4, or -TLR6 blocking Abs or isotype
controlAbs followedby treatmentwith purifiedPE_PGRS17or PE_PGRS11
proteins. Cells were fixed with cold methanol for 15 min and stained with
primary Abs (anti-PE_PGRS 17 or anti-PE_PGRS 11) for 1 h, followed by
incubationwith secondaryAb (Cy5- conjugatedanti-rabbit IgG) in the dark for
1 h at room temperature. Cover slips with cells were mounted on a slide with
fluoromountG, immunofluorescent imageswere acquired by aZeiss LSM510
Meta confocal laser scanning microscope, and the images were analyzed for
the integrated density of the fluorescence and for the area of the cells using
Zeiss LSM image browser software (Zeiss, Oberkochen, Germany).
Immunoprecipitation assay
HEK-293 cells transfected with TLR2 or vector construct and DCs were
washed briefly with ice-cold PBS and lysed in 13 radio immunoprecipi-
tation assay lysis buffer (50 mM Tris-HCl [pH 7.4], 1% NP-40, 0.25% Na-
deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mg/ml each
aprotinin, leupeptin, and pepstatin, 1 mM Na3VO4, 1 mM NaF). The cell
lysate was incubated with PE_PGRS 17 or PE_PGRS 11 immobilized on
Ni-NTA beads at 4˚C overnight on a rotor. The beads were harvested,
washed, and boiled in 53 Laemmli buffer for 5 min. The proteins were
separated on 12% SDS-PAGE followed by transfer of proteins to poly-
vinylidene difluoride membranes (Millipore). The membranes were further
probed with anti-TLR1, -TLR2, -TLR4, or -TLR6 Abs as indicated.
Statistical analysis
Levels of significance for comparison between samples were determined by
Student t test distribution. The data in the graphs are expressed as themean6
SEM.GraphPadPrism3.0 software (GraphPad, SanDiego,CA)was used for
all the statistical analysis.
Results
PE_PGRS 17 and PE_PGRS 11 Ags induce maturation of
human DCs
Several lines of evidence suggest that the members of PE_PGRS
family proteins PE_PGRS17 andPE_PGRS11have a critical role in
the pathogenesis of tuberculosis and in the host innate and adaptive
immune responses to bacilli (33, 38–40). Because DCs are at the
crossroads of innate and adaptive immunity, we first analyzed the
effect of PE_PGRS 17 and PE_PGRS 11 proteins on the maturation
process of human DCs.
ImmatureDCswereculturedwithPE_PGRS17orPE_PGRS11for
48 h, and expression of various surfacemarkers on cells was analyzed
by flowcytometry.Wehave usedAgs at a concentration of 5mg for all
of the experiments after carrying out titration analysis. As shown in
Fig. 1, stimulation of DCs with PE_PGRS 17 and PE_PGRS 11 re-
sulted in the significantly increased expression of costimulatory
molecules CD80, CD86, and CD40, Ag-presenting molecule HLA-
DR, and DC terminal maturation marker CD83, whereas the ex-
pression of DC differentiation marker CD1a was decreased (Fig. 1).
We confirmed that the stimulatory effects of PE_PGRS 17 and
PE_PGRS 11 proteins on DCs were not due to endotoxin or LPS
contamination in the protein preparations. For all of the experi-
ments, we have used protein preparations that were passed through
polymyxin B agarose column. Consequently, we could not detect
endotoxins in protein preparations as analyzed by the E-Toxate kit
(Sigma-Aldrich). Furthermore, a nonrelated mycobacterial lipase
protein produced and processed by the same procedure failed to
trigger expression of maturation markers on DCs (Supplemental
Fig. 1A, 1B). Also, proteinase K treatment abrogated the ability of
PE_PGRS 17 or PE_PGRS 11 to trigger maturation of DCs, in-
dicating that intact protein in its native form was required for
inducing the maturation of DCs (Supplemental Fig. 2).
PE_PGRS 17 and PE_PGRS 11 induce the secretion of
proinflammatory cytokines by DCs
DC-derived cytokines play a critical role in the polarization of T cells
and in mediating inflammatory responses (18, 19). Therefore, we
analyzedwhether PE_PGRSAg-mediatedmaturation process ofDCs
is associatedwith the secretion of proinflammatory cytokines. In fact,
both PE_PGRS 17 and PE_PGRS 11 significantly stimulated DCs to
secrete high levels of IL-6, IL-8, and IL-12 (Fig. 2A–C). However,
untreated DCs secreted negligible amounts of these cytokines. In-
terestingly, PE_PGRS17orPE_PGRS11 failed to trigger secretion of
immunoregulatory and suppressive cytokine IL-10 (data not shown).
PE_PGRS 17 andPE_PGRS 11Ag-stimulatedDCs induceCD4+
T cell proliferation in vitro
Ag-activated and matured DCs can trigger activation and pro-
liferation of CD4+ T cells at very low stimulator to responder ratio
(18–21). In this regard, we ascertained whether maturation of DCs
by PE_PGRS 17 and PE_PGRS 11 Ags is reflected in their ability
to stimulate CD4+ T cells in an allogeneic MLR. As shown in Fig.
3A, DCs matured by PE_PGRS 17 and PE_PGRS 11 Ags sig-
nificantly stimulated CD4+ T cell proliferation as analyzed by [3H]
thymidine incorporation. In concordance with these data, aug-
mented secretion of IL-5 (Supplemental Fig. 3A), IFN-g (Sup-
plemental Fig. 3B), as well as TNF-a (data not shown) by these
DC-stimulated T cells implicate the potential of PE_PGRS 17 and
PE_PGRS 11 Ags to stimulate potent T cell stimulation via DCs.
PE_PGRS 17 and PE_PGRS 11 Ags induce strong T cell
responses ex vivo
WehavepreviouslyshownthatPE_PGRS17andPE_PGRS11exhibit
averyhighantigenic indexfor thepotentialantigenicdeterminants(33
and data not shown). Therefore, we have hypothesized that patients
with tuberculosis have a high frequency of T cells specific for these
proteins. To examine this, we have analyzed the ability of PE_PGRS
17 and PE_PGRS11 to trigger T cell cytokine secretion fromPBMCs
of patients with pulmonary tuberculosis. As demonstrated in Fig. 3B
and 3C, both PE_PGRS 17 and PE_PGRS 11 augmented IFN-g and
IL-5 secretion fromTcells of patientswith pulmonary tuberculosis as
The Journal of Immunology 3497
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compared with healthy subjects. Further, the ratios of cytokine re-
sponses were examined in healthy subjects and in patients with pul-
monary tuberculosis to obtain a broader measure of the effect of
PE_PGRS 17 or PE_PGRS 11 Ags on the balance of immunity.
However, calculation of median ratios of PE_PGRS 17 or PE_PGRS
11 Ag-driven IFN-g/IL-5 indicated more balanced Th1/Th2 re-
sponses in both patients and healthy subjects (data not shown).
PE_PGRS 17 and PE_PGRS 11 proteins recognize TLR2
Innate immune cells express several pattern recognition receptors
(41). Pattern recognition receptors, such as TLRs, recognize path-
ogen-associated molecular patterns on mycobacteria or mycobac-
terial cell wall components, leading to intracellular signaling events,
activation of innate cells, secretion of inflammatory cytokines, and
initiation of immune responses to mycobacteria bacilli (42–45).
Therefore, we aimed at identifying TLR that is recognized by
PE_PGRS 17 and PE_PGRS 11 Ags.
In view of the critical role of TLR1, TLR2, TLR4, and TLR6 in
mediating the recognition of mycobacterial Ags (42, 43, 46–52),
we first analyzed the binding of PE_PGRS 17 or PE_PGRS 11
Ags to TLR2-transfected HEK-293 cells by confocal microscopy.
Interestingly, we found that both PE_PGRS 17 or PE_PGRS 11
specifically recognize TLR2, but neither of these two Ags rec-
ognized control vector DNA-transfected HEK-293 cells (Fig. 4A).
Furthermore, to establish physical interaction of PE_PGRS 17 or
PE_PGRS 11 with TLR2, vector or TLR2-transfected HEK-293
FIGURE 2. PE_PGRS 17 or PE_PGRS 11
triggers DCs to secrete high amounts of proin-
flammatory cytokines. DCs (0.5 3 106 cells/ml)
were cultured with GM-CSF and IL-4 alone
(Control) or GM-CSF, IL-4, and 5 mg/ml
PE_PGRS 17 or PE_PGRS 11 for 48 h, and se-
cretion of IL-6 (A), IL-8 (B), and IL-12 (C) in cell
free culture supernatants was analyzed by cytokine
bead array assay. Data are presented as mean 6
SEM from six independent donors. pp , 0.05
versus Control.
FIGURE 1. PE_PGRS 17 and PE_PGRS 11 induce maturation of human DCs. A and B, Seven-day-old immature DCs (0.53 106 cells/ml) were cultured
with GM-CSF and IL-4 alone (Control) or GM-CSF, IL-4, and 5 mg/ml PE_PGRS 17 or PE_PGRS 11 for 48 h and analyzed for the expression of surface
markers. The percentage of cells expressing the indicated markers is shown in A, whereas mean fluorescence intensities (MFI) are shown in B. Data are
presented as mean 6 SEM from six independent donors. pp , 0.05 versus Control.
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cell extracts were incubated with PE_PGRS 17 or PE_PGRS 11
proteins immobilized on Ni-NTA beads, and pulldown proteins
were analyzed for TLR2 by immunoblotting. Data presented in
Fig. 4B demonstrate that immobilized PE_PGRS 17 or PE_PGRS
11 could pull down TLR2, suggesting PE_PGRS 17 or PE_PGRS
11 Ags interact specifically in a significant manner with TLR2. In
addition, specific interaction of PE_PGRS 17 or PE_PGRS 11 Ags
with TLR2 as opposed to TLR4, TLR1, or TLR6 was further
FIGURE 3. PE_PGRS 17 or PE_PGRS 11 triggers
strong T cell response. A, DCs were cultured with GM-
CSF and IL-4 alone (Control) or GM-CSF, IL-4, and 5
mg/ml of PE_PGRS 17 or PE_PGRS 11 for 48 h. Fol-
lowing extensive washings, DCs were cocultured with
allogenic CD4+ T cells at various DC:T cell ratios. The
T cell proliferation was quantified by [3H]thymidine in-
corporation, and values were expressed as cpm (mean 6
SEM of quadruplet values). The data are representative of
one of three independent donors. B and C, PBMCs ob-
tained from patients with tuberculosis (n = 9) and healthy
control subjects (n = 4) were cultured with or without
5 mg/ml PE_PGRS17 or PE_PGRS 11, and cell-free su-
pernatants collected on day 4 were tested for concen-
trations of secreted IFN-g (B) and IL-5 (C). Data are
presented as mean 6 SEM. pp , 0.05 versus Control;
ppp , 0.05 versus PE_PGRS 17 (Healthy Controls);
pppp, 0.05 versus PE_PGRS 11 (Healthy Controls).
FIGURE 4. PE_PGRS 17 and PE_PGRS 11 proteins interact with TLR2. A, TLR2 or vector-transfected HEK-293 cells were treated with PE_PGRS 17
or PE_PGRS 11. The cells were further stained with Ab specific to PE_PGRS 17 or PE_PGRS 11 followed by Cy5-labeled secondary Ab. The immu-
nofluorescent staining of cells was analyzed by confocal microscopy. B, Cell lysates from HEK-293 cells transfected with TLR2 or vector were incubated
with PE_PGRS 17 or PE_PGRS 11 immobilized on Ni-NTA beads. The proteins bound on beads were extracted and analyzed for the presence of TLR2 by
immunoblotting. C, Cell lysates from DCs were incubated with PE_PGRS 17 or PE_PGRS 11 immobilized on Ni-NTA beads, and bead-bound proteins
were loaded on gel followed by immunoblotting for TLR1, TLR2, TLR4, and TLR6. D, DCs were pretreated with anti-TLR1, -TLR2, -TLR4, and -TLR6
blocking or isotypic Abs followed by incubation with PE_PGRS 17 or PE_PGRS11. Specificity of interaction of PE_PGRS 17 or PE_PGRS 11 was
evaluated by confocal microscopic analysis. Data are representative of two independent experiments. BF, bright field.
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validated by pulldown assay using whole cell extracts from DCs
that endogenously express various TLRs. As demonstrated in Fig.
4C, PE_PGRS 17 or PE_PGRS 11 interacted specifically with
TLR2 as opposed to TLR1, TLR4, and TLR6. Further, to ascertain
physical binding of PE_PGRS 17 or PE_PGRS 11 Ags specifically
to TLR2 on DC surface, we blocked respective TLRs with
FIGURE 5. Maturation of DCs
triggered by PE_PGRS 17 and
PE_PGRS 11 involves ERK1/2 and
p38 MAPK-dependent activation of
NF-kB. DCs were treated with
PE_PGRS 17 (A) or PE_PGRS 11 (B)
for indicated time points, and phos-
phorylation of ERK1/2 (pERK1/2)
and p38 MAPK (pp38) was analyzed
by immunoblotting. C, PE_PGRS 17
and PE_PGRS 11 trigger nuclear
translocation of p65 NF-kB. D, DCs
were pretreated with ERK1/2 in-
hibitor (U0126, 10 mM) and p38 in-
hibitor (SB203580, 20 mM) followed
by treatment with PE_PGRS 11, and
nuclear translocation of p65 NF-kB
was analyzed. Data are representative
of three independent experiments.
Med, medium.
FIGURE 6. Involvement of ERK1/2, p38, and NF-kB pathways in PE_PGRS 17 or PE_PGRS 11-induced maturation of DCs. DCs were treated with
pharmacological inhibitors of ERK1/2 (U0126, 10mM), p38 (SB203580, 20mM),NF-kB (TPCK, 20mM), orDMSO (vehicle control) for 1 h prior to treatment
with PE_PGRS17 (A) or PE_PGRS11 (B) for 48 h. The expression of CD80 andCD86was analyzed by flow cytometry.C andD, DCswere treated as inA orB,
and the level of secreted IL-6 was analyzed. Data are presented as mean6 SEM from three independent donors. pp, 0.05 versus PE_PGRS 17; ppp, 0.05
versus PE_PGRS 11.
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blocking Abs, and confocal microscopic studies clearly ascertain
the specific interaction of PE_PGRS 17 or PE_PGRS 11 with
TLR2 on DCs (Fig. 4D). Furthermore, the TLR2 dominant-neg-
ative construct significantly reduced PE_PGRS 17 or PE_PGRS
11 Ag-triggered NF-kB promoter activity, as well as expression of
TLR2 target gene cyclooxygenase-2 at transcript as well as its
protein levels (data not shown). Additionally, the ability of
PE_PGRS 17 or PE_PGRS 11 to trigger the expression of TLR2
target gene cyclooxygenase-2 was not compromised in macro-
phages derived from TLR4-defective C3H/HeJ mice (data not
shown). These results thus signify the role of TLR2 in PE_PGRS
17- or PE_PGRS 11-mediated signaling events.
Role of MAPK and NF-kB pathways in PE_PGRS 17 or
PE_PGRS 11 Ag-induced maturation of DCs
Maturation of DCs induced by mycobacterial Ags often involves
activation of NF-kB and MAPK pathways such as ERK1/2 and
p38 MAPK (53–58). In this context, we found that both PE_PGRS
17 or PE_PGRS 11 Ags trigger the activation of MAPKs ERK1/2
and p38 (Fig. 5A, 5B) and significant translocation of p65 NF-kB
from the cytosol to the nucleus within 60 min of stimulation (Fig.
5C) in human DCs. Interestingly, we found that U0126 (ERK1/2
inhibitor) and SB203580 (p38 MAPK inhibitor) abolished
PE_PGRS 17- or PE_PGRS 11-induced nuclear translocation of
NF-kB (Fig. 5D and data not shown). These results thus indicate
that PE_PGRS 17 or PE_PGRS 11 proteins trigger DC maturation
via MAPK-dependent activation of the NF-kB pathway.
Furthermore, pharmacological inhibitors U0126 (ERK1/2),
SB203580 (p38), TPCK (NF-kB) (59, 60), or Bay 11-0782 (NF-
kB) (61) abrogated PE_PGRS 17- or PE_PGRS 11-induced ex-
pression of costimulatory molecules CD80, CD86, and CD40
(Fig. 6A, 6B and data not shown) and secretion of inflammatory
cytokines (shown with IL-6 as an example) from DCs (Fig. 6C,
6D). Together, our results thus suggest that NF-kB and MAPK
pathways represent important signaling partnership links in
PE_PGRS 17- or PE_PGRS 11-triggered maturation and activa-
tion of human DCs.
IFN-g potentiates PE_PGRS 17- or PE_PGRS 11-induced
maturation of DCs
Among proinflammatory cytokines, IFN-g occupies an important
place, as it regulates the diverse antimycobacterial cellular func-
tions, such as activation of innate cells, Ag processing and pre-
sentation, and generation of effector CTLs. Indeed, IFN-g–deficient
mice exhibit susceptibility to mycobacterial infection (62). It was
suggested that the lack of protective immunity in IFN-g–deficient
mice was primarily due to their inability to activate innate cells. In
this perspective, we hypothesize that the priming of human DCs
with IFN-g leads to augmentation of PE_PGRS 17 or PE_PGRS 11
Ag-induced DC maturation and secretion of inflammatory cyto-
kines. Immature DCs were primed with 1000 IU/ml IFN-g for 6 h
followed by treatment with PE_PGRS 17 or PE_PGRS 11 for 42 h.
As represented in Fig. 7A, pretreatment with IFN-g led to en-
hancement of PE_PGRS 17- or PE_PGRS 11-induced maturation
process of DCs as exemplified by the enhanced expression of cos-
timulatory molecules CD80, CD86, and CD40. Additionally, IFN-g
priming augmented PE_PGRS 17 or PE_PGRS 11 Ag-mediated
secretion of both IL-6 and IL-8 by DCs (Fig. 7B).
Discussion
DCs are principal mediators of initiation aswell as activation of host
immune responses to tuberculosis infection. Activation of T cell-
mediated immunity during infection is regulated by the signaling
cascades that are initiated upon encounter of Ags by DCs and
FIGURE 7. IFN-g treatment augments PE_PGRS 17 and PE_PGRS 11-induced DC maturation. DCs were treated either with PE_PGRS 17 or PE_PGRS
11 alone or with IFN-g for 48 h, and expression of maturation markers CD80, CD86, and CD40 (A) and secretion of IL-6 and IL-8 (B) was analyzed. Data
are presented as mean 6 SEM from three independent donors. pp , 0.05 versus PE_PGRS 17; ppp , 0.05 versus PE_PGRS 11.
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subsequent productive engagement of TCR on T cells in the context
of costimulation by DCs (18, 19). Further, cytokines secreted from
DCs, such as IL-6, IL-8, IL-12, or IL-10, direct the T cell polari-
zation toward Th1, Th2, Th17, or regulatory T cells (19). Inter-
estingly, mycobacterial Ags have been shown to possess the
potential of regulating immune responses in humans and animal
models (31, 26, 63). Although mycobacteria reside within phag-
olysosomes, cell wall Ags including lipoarabinomannan, phos-
phatidyl-myoinositol mannosides, and PE_PGRS Ags are released
and traffic out of the mycobacterial phagosome into endocytic
compartments as well as gain access to the extracellular environ-
ment in the form of exocytosed vesicles (14, 61, 64, 65). In this
perspective, deciphering the interaction of cell wall Ags of patho-
genic mycobacteria with human DCs is important to understand the
molecular pathogenesis of tuberculosis and host response to my-
cobacteria and to conceive prospective vaccine candidates.
As described previously, the PE_PGRS subfamily of PE genes is
enriched in genes with a high probability of being essential in M.
tuberculosis survival in the host and hence can act as virulent
factors (30, 31). Further, selective expression of specific PE_PGRS
proteins in vivo could address the various pathological attributes of
M. tuberculosis. In this regard, we explored the modulation of
human DC activation by PE_PGRS Ags of M. tuberculosis.
PE_PGRS 17 and PE_PGRS 11 Ags display differential antigenic
profiles and are associated with pathological conditions, as evident
from DNA microarray expression data (39, 40, 66). In comparison
with other PE_PGRS Ags, the expression of PE_PGRS 17 and
PE_PGRS 11 is selectively increased inM. tuberculosis bacilli upon
infectionofmousemacrophages (39), andPE_PGRS17was shown to
be upregulated, by at least 8-fold, in human brain microvascular en-
dothelial cell-associatedM. tuberculosis (66). In addition, PE_PGRS
17 and PE_PGRS 11 have been detected in lung tissues of infected
mice (40, 67). We have previously shown that among all the proteins
belonging to the PE family (including PE_PGRSAgs), PE_PGRS 17
and PE_PGRS 11 exhibit a very high antigenic index for the potential
antigenic determinants as mentioned (33 and data not shown). In
addition, our previous studies have suggested that among studied PE
Ags, PE_PGRS 17 and PE_PGRS 11 exhibit immunoreactivity in
sera from adult patients with pulmonary tuberculosis and child pa-
tients with pulmonary or extrapulmonary infection. More impor-
tantly, the immunoreactivity elicited in patients’ sera demonstrated
differential and stronger reactivities of the humoral Abs to PE_PGRS
17 and PE_PGRS 11 compared with other PE or mycobacterial Ags.
These observations suggested the possible differential serodiagnostic
utility of PE_PGRS 17 and PE_PGRS 11 during different stages of
tuberculosis infection (33 and data not shown). Further, PE_PGRS 17
and PE_PGRS11 elicited stronger IFN-g and IL-5 cytokine secretion
from T cells in patients with pulmonary tuberculosis compared with
healthy subjects. In view of these observations, we proposed that
PE_PGRS 17 and PE_PGRS 11 represent an ideal model to study
mycobacteria-specific innate immune responses in humans.
We show that PE_PGRS 17 and PE_PGRS 11 proteins induce
maturation of DCs characterized by upregulation of costimulatory
and Ag-presenting molecules with a concomitant increased pro-
duction of proinflammatory cytokines. Further, PE_PGRS protein-
matured DCs were functionally competent as they induced robust
proliferation and secretion of cytokines from CD4+ T cells, thus
implicating the immunopotent nature of PE_PGRS 17 and
PE_PGRS 11.
TLRs in general and TLR2 specifically play a pivotal role in the
activation of inflammatory immune responses by mycobacteria
(41–44). The activation threshold of TLR2 signaling in DCs
during infection could act as a rate-limiting step that eventually
controls the strength of innate or adaptive immune responses.
TLR2 signaling in DCs is suggested to involve the participation of
MAPK and NF-kB signaling pathways (57, 61). In this context,
PE_PGRS 17 and PE_PGRS 11 interact with cell surface TLR2,
and disruption of the activation of MAPK and NF-kB pathways
abrogated PE_PGRS Ag-induced maturation of DCs or secretion
of inflammatory cytokines. These results implicate signaling in-
tegration of TLR2, MAPKs, and NF-kB pathways during myco-
bacterial Ag-triggered DC maturation. In addition to PE_PGRS
Ags described in our study, a few other mycobacterial Ags, ESAT-
6 and Ag85b, are reported to trigger murine DC maturation (68).
However, our study is the first of its kind to report a novel activity
associated with two selectively expressed PE_PGRS proteins to
which hitherto no functional annotation has been accredited as yet.
Many studies have clearly emphasized the observation of a lack
of adequate immune response in patients with tuberculosis against
many well-characterized Ags of tuberculosis bacilli. This lack of
immune response is more prominent in newly diagnosed cases of
pulmonary tuberculosis, wherein the host immune system is not
sufficiently primed to elicit a strong immune response against most
Ags of M. tuberculosis (33). The production of a key cytokine,
IFN-g, by PBMCs is shown to be severely compromised in pa-
tients with tuberculosis (69). In this regard, augmentation by IFN-
g of PE_PGRS protein-mediated activation of DCs could act as
a determining factor in the initiation of robust innate immunity to
Mycobacterium. We show that in vitro priming of DCs with IFN-g
not only enhances the maturation of DCs but also the secretion of
proinflammatory cytokines. This observation implicates a crucial
role of IFN-g in the pathogenesis of tuberculosis as well as in its
utilization as an immunoadjuvant. Overall, our study assigns
a novel role for PE_PGRS Ags of M. tuberculosis in the activation
of innate immunity and supports their possible utility in new
therapeutic strategies to combat tuberculosis.
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